Cargando…
Platelet membrane-camouflaged nanoparticles carry microRNA inhibitor against myocardial ischaemia‒reperfusion injury
The incidence of myocardial ischaemia‒reperfusion injury (MIRI) is increasing every year, and there is an urgent need to develop new therapeutic approaches. Nrf2 is thought to play a protective role during MIRI and it is regulated by microRNAs (miRNAs). This study focused on PLGA nanoparticles camou...
Autores principales: | Wang, Tianyi, Zhou, Tingting, Xu, Mingming, Wang, Shuo, Wu, Anqi, Zhang, Mingyang, Zhou, You Lang, Shi, Jiahai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531416/ https://www.ncbi.nlm.nih.gov/pubmed/36195952 http://dx.doi.org/10.1186/s12951-022-01639-8 |
Ejemplares similares
-
Platelet-Membrane-Encapsulated Carvedilol with Improved Targeting Ability for Relieving Myocardial Ischemia–Reperfusion Injury
por: Zhou, Tingting, et al.
Publicado: (2022) -
MicroRNA-146a protects against myocardial ischaemia reperfusion injury by targeting Med1
por: Zhang, Tiantian, et al.
Publicado: (2019) -
Platelets in cardiac ischaemia/reperfusion injury: a promising therapeutic target
por: Ziegler, Melanie, et al.
Publicado: (2019) -
Inhibition of adenosine kinase attenuates myocardial ischaemia/reperfusion injury
por: Wang, Wenjun, et al.
Publicado: (2021) -
The cardioprotective potential of valsartan in myocardial ischaemia reperfusion injury
por: Hadi, Najah R., et al.
Publicado: (2015)